CD274 and hematocrit: Some medications may be associated with an increased risk of AITDs or thyroid function disorders; e.g., the increasingly widespread use (in various clinical settings) of medications such as amiodarone, tyrosine kinase inhibitors, immune checkpoint inhibitors therapy, PD-(L)1-Ab, lithium, interferon-α, and so on may alter the prevalence of HT.